Roche Seeks To Broaden Arthritis Drug Roactemra Use In EU, US
ZURICH, Oct 18 (Reuters) - Roche Holding AG (ROG.VX) is seeking approval to broaden the use of its arthritis drug Roactemra in Europe and the United States to treat a type of childhood arthritis, giving the group a lift after a series of setbacks.